Treatment with therapeutic proteins is an attractive approach to targeting a number of challenging diseases. Unfortunately, the native proteins themselves are often unstable in physiological conditions, reducing bioavailability and therefore increasing the dose that is required. Conjugation with poly(ethylene glycol) (PEG) is often used to increase stability, but this has a detrimental effect on bioactivity. Here, we introduce conjugation with zwitterionic polymers such as poly(carboxybetaine). We show that poly(carboxybetaine) conjugation improves stability in a manner similar to PEGylation, but that the new conjugates retain or even improve the binding affinity as a result of enhanced protein–substrate hydrophobic interactions. This chemistry opens a new avenue for the development of protein therapeutics by avoiding the need to compromise between stability and affinity.
This is a preview of subscription content
Subscribe to Journal
Get full journal access for 1 year
only $9.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Harris, J. M. & Chess, R. B. Effect of pegylation on pharmaceuticals. Nature Rev. Drug Discov. 2, 214–221 (2003).
Jevsevar, S., Kunstelj, M. & Porekar, V. G. PEGylation of therapeutic proteins. Biotechnol. J. 5, 113–128 (2010).
Fishburn, C. S. The pharmacology of PEGylation: balancing PD with PK to generate novel therapeutics. J. Pharm. Sci. 97, 4167–4183 (2008).
Veronese, F. M. Peptide and protein PEGylation: a review of problems and solutions. Biomaterials 22, 405–417 (2001).
Shaunak, S. et al. Site-specific PEGylation of native disulfide bonds in therapeutic proteins. Nature Chem. Biol. 2, 312–313 (2006).
Veronese, F. M. & Mero, A. The impact of PEGylation on biological therapies. Biodrugs 22, 315–329 (2008).
Chapman, A. P. PEGylated antibodies and antibody fragments for improved therapy: a review. Adv. Drug Deliv. Rev. 54, 531–545 (2002).
Rodriguez-Martinez, J. A., Rivera-Rivera, I., Sola, R. J. & Griebenow, K. Enzymatic activity and thermal stability of PEG-alpha-chymotrypsin conjugates. Biotechnol. Lett. 31, 883–887 (2009).
Jiang, S. Y. & Cao, Z. Q. Ultralow-fouling, functionalizable, and hydrolyzable zwitterionic materials and their derivatives for biological applications. Adv. Mater. 22, 920–932 (2010).
Yang, W., Zhang, L., Wang, S. L., White, A. D. & Jiang, S. Y. Functionalizable and ultra stable nanoparticles coated with zwitterionic poly(carboxybetaine) in undiluted blood serum. Biomaterials 30, 5617–5621 (2009).
Gref, R. et al. Biodegradable long-circulating polymeric nanospheres. Science 263, 1600–1603 (1994).
Prime, K. L. & Whitesides, G. M. Self-assembled organic monolayers—model systems for studying adsorption of proteins at surfaces. Science 252, 1164–1167 (1991).
Szleifer, I. Polymers and proteins: interactions at interfaces. Curr. Opin. Solid State Mater. Sci. 2, 337–344 (1997).
Kane, R. S., Deschatelets, P. & Whitesides, G. M. Kosmotropes form the basis of protein-resistant surfaces. Langmuir 19, 2388–2391 (2003).
Cacace, M. G., Landau, E. M. & Ramsden, J. J. The Hofmeister series: salt and solvent effects on interfacial phenomena. Q. Rev. Biophys. 30, 241–277 (1997).
Georgiev, G. S. et al. Self-assembly, anti polyelectrolyte effect, and nonbiofouling properties of polyzwitterions. Biomacromolecules 7, 1329–1334 (2006).
Treethammathurot, B., Ovartlarnporn, C., Wungsintaweekul, J., Duncan, R. & Wiwattanapatapee, R. Effect of PEG molecular weight and linking chemistry on the biological activity and thermal stability of PEGylated trypsin. Int. J. Pharm. 357, 252–259 (2008).
Rodriguez-Martinez, J. A. et al. Stabilization of alpha-chymotrypsin upon PEGylation correlates with reduced structural dynamics. Biotechnol. Bioeng. 101, 1142–1149 (2008).
Pegram, L. M. & Record, M. T. Hofmeister salt effects on surface tension arise from partitioning of anions and cations between bulk water and the air–water interface. J. Phys. Chem. B 111, 5411–5417 (2007).
Lo Conte, L., Chothia, C. & Janin, J. The atomic structure of protein–protein recognition sites. J. Mol. Biol. 285, 2177–2198 (1999).
Zhao, H. Effect of ions and other compatible solutes on enzyme activity, and its implication for biocatalysis using ionic liquids. J. Mol. Catal. B 37, 16–25 (2005).
Ngo, T. T. & Narinesingh, D. Kosmotropes enhance the yield of antibody purified by affinity chromatography using immobilized bacterial immunoglobulin binding proteins. J. Immunoassay Immunochem. 29, 105–115 (2008).
Schubert, U. S., Knop, K., Hoogenboom, R. & Fischer, D. Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. Angew. Chem. Int. Ed. 49, 6288–6308 (2010).
Cao, Z. Q., Yu, Q. M., Xue, H., Cheng, G. & Jiang, S. Y. Nanoparticles for drug delivery prepared from amphiphilic PLGA zwitterionic block copolymers with sharp contrast in polarity between two blocks. Angew. Chem. Int. Ed. 49, 3771–3776 (2010).
This work was supported by the Office of Naval Research (N000140910137 and N000141010600) and the National Science Foundation (DMR-1005699). A.J.K. was partially supported through a National Cancer Institute training grant (T32CA138312). The authors thank the members of the Jiang research group, especially Zhiqiang Cao and Hong Xue, for helpful discussions.
The authors declare no competing financial interests.
About this article
Cite this article
Keefe, A., Jiang, S. Poly(zwitterionic)protein conjugates offer increased stability without sacrificing binding affinity or bioactivity. Nature Chem 4, 59–63 (2012). https://doi.org/10.1038/nchem.1213
Transdermal delivery of a somatostatin receptor type 2 antagonist using microneedle patch technology for hypoglycemia prevention
Drug Delivery and Translational Research (2022)
Rare Metals (2022)
Journal of Polymer Research (2022)
Journal of Sol-Gel Science and Technology (2022)
Scientific Reports (2020)